Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study
- DOI
- 10.3390/jcm14217801
- Published
- 2025-11-03
- Container
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/jcm14217801,
title = {Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study},
author = {Giammarco Mocci and Antonio Tursi and Franco Scaldaferri and Daniele Napolitano and Daniela Pugliese and Giovanni Maconi and Giovanni Cataletti and Roberta Pica and Claudio Cassieri and Edoardo Vincenzo Savarino and Caterina De Barba and Francesco Costa and Linda Ceccarelli and Manuela Marzo and Walter Elisei and Rita Monterubbianesi and Roberto Faggiani and Giovanni Lombardi and Marta Patturelli and Davide Giuseppe Ribaldone and Lorenzo Bertani and Stefano Rodinò and Ladislava Sebkova and Giorgia Bodini and Andrea Pasta and Giuseppe Pranzo and Mariaelena Serio and Antonella Scarcelli and Ileana Luppino and Antonio Ferronato and Rocco Spagnuolo and Francesco Luzza and Antonietta Gerarda Gravina and Raffaele Pellegrino and Giuliana Vespere and Silvia Sedda and Vittorio D’Onofrio and Leonardo De Luca and Leonardo Allegretta and Alessia Immacolata Cazzato and Libera Fanigliuolo and Laurino Grossi and Fabio Cortellini and Giacomo Forti and Paolo Tonti and Viviana Neve and Simona Piergallini and Michela Di Fonzo and Federico Iacopini and Pietro Capone and Federica Gaiani and Stefano Kayali and Caterina Mucherino and Elvira D’Antonio and Laura Montesano and Andrea Cocco and Berardino D’Ascoli and Raffaele Colucci and Francesco Bachetti and Giorgia Orrù and Francesca Maria Onidi and Paolo Usai Satta and Marcello Picchio and Alfredo Papa},
year = {2025},
journal = {Journal of Clinical Medicine},
doi = {10.3390/jcm14217801},
url = {https://doi.org/10.3390/jcm14217801}
}RIS
TY - JOUR TI - Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study AU - Giammarco Mocci AU - Antonio Tursi AU - Franco Scaldaferri AU - Daniele Napolitano AU - Daniela Pugliese AU - Giovanni Maconi AU - Giovanni Cataletti AU - Roberta Pica AU - Claudio Cassieri AU - Edoardo Vincenzo Savarino AU - Caterina De Barba AU - Francesco Costa AU - Linda Ceccarelli AU - Manuela Marzo AU - Walter Elisei AU - Rita Monterubbianesi AU - Roberto Faggiani AU - Giovanni Lombardi AU - Marta Patturelli AU - Davide Giuseppe Ribaldone AU - Lorenzo Bertani AU - Stefano Rodinò AU - Ladislava Sebkova AU - Giorgia Bodini AU - Andrea Pasta AU - Giuseppe Pranzo AU - Mariaelena Serio AU - Antonella Scarcelli AU - Ileana Luppino AU - Antonio Ferronato AU - Rocco Spagnuolo AU - Francesco Luzza AU - Antonietta Gerarda Gravina AU - Raffaele Pellegrino AU - Giuliana Vespere AU - Silvia Sedda AU - Vittorio D’Onofrio AU - Leonardo De Luca AU - Leonardo Allegretta AU - Alessia Immacolata Cazzato AU - Libera Fanigliuolo AU - Laurino Grossi AU - Fabio Cortellini AU - Giacomo Forti AU - Paolo Tonti AU - Viviana Neve AU - Simona Piergallini AU - Michela Di Fonzo AU - Federico Iacopini AU - Pietro Capone AU - Federica Gaiani AU - Stefano Kayali AU - Caterina Mucherino AU - Elvira D’Antonio AU - Laura Montesano AU - Andrea Cocco AU - Berardino D’Ascoli AU - Raffaele Colucci AU - Francesco Bachetti AU - Giorgia Orrù AU - Francesca Maria Onidi AU - Paolo Usai Satta AU - Marcello Picchio AU - Alfredo Papa PY - 2025 JO - Journal of Clinical Medicine DO - 10.3390/jcm14217801 UR - https://doi.org/10.3390/jcm14217801 ER -
APA
Mocci, G., Tursi, A., Scaldaferri, F., Napolitano, D., Pugliese, D., Maconi, G., Cataletti, G., Pica, R., Cassieri, C., Savarino, E. V., Barba, C. D., Costa, F., Ceccarelli, L., Marzo, M., Elisei, W., Monterubbianesi, R., Faggiani, R., Lombardi, G., Patturelli, M., Ribaldone, D. G., Bertani, L., Rodinò, S., Sebkova, L., Bodini, G., Pasta, A., Pranzo, G., Serio, M., Scarcelli, A., Luppino, I., Ferronato, A., Spagnuolo, R., Luzza, F., Gravina, A. G., Pellegrino, R., Vespere, G., Sedda, S., D’Onofrio, V., Luca, L. D., Allegretta, L., Cazzato, A. I., Fanigliuolo, L., Grossi, L., Cortellini, F., Forti, G., Tonti, P., Neve, V., Piergallini, S., Fonzo, M. D., Iacopini, F., Capone, P., Gaiani, F., Kayali, S., Mucherino, C., D’Antonio, E., Montesano, L., Cocco, A., D’Ascoli, B., Colucci, R., Bachetti, F., Orrù, G., Onidi, F. M., Satta, P. U., Picchio, M., & Papa, A. (2025). Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14217801
Source records
- crossref · retrieved 2026-09-26T18:15:57.736Z